Top 4 Mid-Cap Stocks In The Biotechnology Industry With The Highest Cash
News | 02 July 2012
Below are the top mid-cap biotechnology stocks on the NYSE and the NASDAQ in terms of cash. Illumina (NASDAQ: ILMN) had $1.27 billion in total cash and $815.97 million in total debt for the latest quarter. Onyx Pharmaceuticals (NASDAQ: ONXX) had ...
Click on the link to read the full article at Benzinga
(This link will open in a new window)
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
